Medical device supply chains are under increasing pressure as global disruption becomes a constant rather than an exception. From geopolitical volatility to material scarcity and regulatory complexity, the sector now operates in an environment where even minor shocks can have far-reaching consequences. This article explores the structural vulnerabilities shaping today’s MedTech supply networks and highlights why traditional approaches are no longer sufficient. It outlines how leading organisations are rethinking resilience not just as risk mitigation, but as a source of competitive advantage in an increasingly unpredictable world. Download the full article to uncover the strategies that are helping companies respond faster, protect patient outcomes, and maintain operational continuity.

The DTP Portfolio Test: A Decision Framework for Direct-to-Patient Investment by Pharma

John D'Angelo, M.D. , President and CEO of Northwell Health joins A&M Healthcare Industry Group's Jamie LaGuardia-Frie and David Shulkin, M.D. to explore how health systems can move beyond fragmented care delivery to create a model where patients feel supported across every step of their journey.

Redesign admin work with an ESS to standardize, govern, and deliver at scale: Cut costs, boost productivity, and strengthen long-term business viability.